Advertisement

Senile Atopic Dermatitis

  • Ryoji TaneiEmail author
Chapter

Abstract

Atopic dermatitis (AD) in the elderly represents a newly defined subgroup of AD. Elderly patients with AD show some characteristic clinical manifestations. Skin manifestations of elderly AD basically match those of adolescent/adult AD, but a lack of involvement of the folds of the elbows and knees is more common than the classic sign of localized lichenification in those folds. Elderly patients with immunoglobulin (Ig)E-allergic AD show high rates of positivity for specific IgE antibodies against house dust mites. In immunohistopathology, IgE-mediated allergic inflammation with IgE+ mast cells and IgE+ dendritic cells (i.e., Langerhans cells and inflammatory dendritic cells) in association with environmental allergens (e.g., house dust mites) may exist in the lichenified eczema of IgE-allergic elderly AD. The prevalence of elderly AD, which shows a tendency toward a male predominance, is approximately 1–3% among elderly populations in industrialized countries. In clinical practice, most elderly patients with AD obtain amelioration of skin manifestations once suitable management is implemented, but most elderly patients with AD still reach the end of life with AD. AD should now be considered as a lifelong allergic condition in some populations.

Keywords

Clinical manifestations Elderly Immunohistopathology Immunoglobulin E Prognosis 

Notes

Acknowledgments

The author thanks the Japanese Journal of Allergology (Japanese Society of Allergology) and Geriatrics & Gerontology International (Japan Geriatric Society and Wiley) for the permission to reuse a table, figures, and portions of text from original articles (Refs. 7, 8) in those journals.

References

  1. 1.
    Sulzberger MB, Goodman J. The relative importance of specific skin hypersensitivity in adult atopic dermatitis. JAMA. 1936;106:1000–3.CrossRefGoogle Scholar
  2. 2.
    Nishioka K. Atopic eczema of adult type in Japan. Australas J Dermatol. 1996;37(Suppl):S7–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Tanei R, Katsuoka K. Clinical analyses of atopic dermatitis in the aged. J Dermatol. 2008;35:562–9.CrossRefPubMedGoogle Scholar
  4. 4.
    Bozek A, Fisher A, Filipowska B, Mazur B, Jazab J. Clinical features and immunological markers of atopic dermatitis in elderly patients. Int Arch Allergy Immunol. 2012;157:372–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Bieber T, Bussmann C. Atopic dermatitis. In: Bolognia JL, Jorizzo JL, Schaffer JV, editors. Dermatology, vol. 1. 3rd ed. Amsterdam: Elsevier; 2012. p. 203–17.Google Scholar
  6. 6.
    Tanei R. Atopic dermatitis in the elderly. Inflamm Allergy Drug Targets. 2009;8:394–404.CrossRefGoogle Scholar
  7. 7.
    Tanei R. Atopic dermatitis in the elderly. Jpn J Allergol. 2015;64:918–25. (in Japanese)Google Scholar
  8. 8.
    Tanei R, Hasegawa Y. Atopic dermatitis in older adults: a viewpoint from geriatric dermatology. Geriatr Gerontol Int. 2016;16(Suppl. 1):75–86.CrossRefPubMedGoogle Scholar
  9. 9.
    Leung DYM, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Invest. 2004;113:651–7.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Tokura Y. Extrinsic and intrinsic types of atopic dermatitis. J Dermatol Sci. 2010;58:1–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Park JH, Choi YL, Namkung JH, Kim WS, Lee JH, Park HJ, et al. Characteristics of extrinsic and intrinsic atopic dermatitis in infancy: correlations with laboratory variables. Br J Dermatol. 2006;155:778–83.CrossRefPubMedGoogle Scholar
  12. 12.
    Tanei R. Clinical characteristics, treatments, and prognosis of atopic eczema in the elderly. J Clin Med. 2015;4:979–97.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Smith CJ, Alexander LM, Kenney WL. Nonuniform, age-related decrements in regional sweating and skin blood flow. Am J Physiol Regul Integr Comp Physiol. 2013;305:R877–85.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Takahashi A, Murota H, Matsui S, Kijima A, Kitaba S, Lee JB, et al. Decreased sudomotor function is involved in the formation of atopic eczema in the cubital fossa. Allergol Int. 2013;62:473–8.CrossRefPubMedGoogle Scholar
  15. 15.
    Shiohara T, Doi T, Hayakawa J. Defective sweating responses in atopic dermatitis. In: Shiohara T, editor. Pathogenesis and management of atopic dermatitis. Basel: Karger; 2011. p. 68–79.CrossRefGoogle Scholar
  16. 16.
    Hide M, Tanaka T, Yamamura Y, Koro O, Yamamoto S. IgE-mediated hypersensitivity against human sweat antigen in patients with atopic dermatitis. Acta Derm Venereol. 2002;82:335–40.CrossRefPubMedGoogle Scholar
  17. 17.
    Bieber T. Atopic dermatitis. N Engl J Med. 2008;358:1483–94.CrossRefPubMedGoogle Scholar
  18. 18.
    Benedetto AD, Agnihothri R, McGirt LY, Bankova LG, Beck LA. Atopic dermatitis: a disease caused by innate immune defects? J Invest Dermatol. 2009;129:14–30.CrossRefPubMedGoogle Scholar
  19. 19.
    Kabashima K. New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity. J Dermatol Sci. 2013;70:3–11.CrossRefPubMedGoogle Scholar
  20. 20.
    Eyerich K, Novak N. Immunology of atopic eczema: overcoming the Th1/Th2 paradigm. Allergy. 2013;68:974–82.CrossRefPubMedGoogle Scholar
  21. 21.
    Werfel T, Allam JP, Biedermann T, Eyerich K, Gilles S, Guttman-Yassky E, et al. Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. J Allergy Clin Immunol. 2016;138:336–49.CrossRefPubMedGoogle Scholar
  22. 22.
    Tanei R, Hasegawa Y, Sawabe M. Abundant immunoglobulin E-positive cells in skin lesions support an allergic etiology of atopic dermatitis in the elderly. J Eur Acad Dermatol Venereol. 2013;27:952–60.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Guttman-Yassky E, Lowes MA, Fuentes-Duculan J, Whynot J, Novitskaya I, Cardinale I, et al. Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis. J Allergy Clin Immunol. 2007;119:1210–7.CrossRefPubMedGoogle Scholar
  24. 24.
    Bruynzeel-Koomen C, van Wichen DF, Toonstra J, Berrens L, Bruynzeel PL. The presence of IgE molecules on epidermal Langerhans cells in patients with atopic dermatitis. Arch Dermatol Res. 1986;278:1993–205.CrossRefGoogle Scholar
  25. 25.
    Hammad H, Plantinga M, Deswarte K, Pouliot P, Willart MAM, Kool M, et al. Inflammatory dendritic cells—not basophils—are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen. J Exp Med. 2010;207:2097–111.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Katayama I, Tanei R, Yokozeki H, Nishioka K, Dohi Y. Induction of eczematous skin reaction in experimentally induced hyperplastic skin of Balb/C mice by monoclonal anti-DNP IgE antibody: possible implication for skin lesion formation in atopic dermatitis. Int Arch Allergy Appl Immunol. 1990;93:148–54.CrossRefPubMedGoogle Scholar
  27. 27.
    Okada M, Terui T, Honda M, Tanaka M, Chikama R, Tabata N, et al. Cutaneous late phase reaction in adult atopic dermatitis patients with high serum IgE antibody to Dermatophagoides farinae: correlation with IL-5 production by allergen-stimulated peripheral blood mononuclear cells. J Dermatol Sci. 2002;29:73–84.CrossRefPubMedGoogle Scholar
  28. 28.
    Thepen T, Langeveld-Wildschut EG, Bihari IC, van Wichen DF, van Reijsen FC, Mudde GC, et al. Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial Th2 response to a Th1 response in situ: an immunocytochemical study. J Allergy Clin Immunol. 1996;97:828–37.CrossRefPubMedGoogle Scholar
  29. 29.
    Bieber T. FcєRI-expressing antigen-presenting cells: new players in atopic game. Immunol Today. 1997;18:311–3.CrossRefPubMedGoogle Scholar
  30. 30.
    Stingl G, Maurer D. IgE-mediated allergen presentation via Fc Epsilon Rl on antigen-presenting cells. Int Arch Allergy Immunol. 1997;113:24–9.CrossRefPubMedGoogle Scholar
  31. 31.
    Maeda K, Yamamoto K, Tanaka Y, Anan S, Yoshida H. House dust mite (HDM) antigen in naturally occurring lesions of atopic dermatitis (AD): the relationship between HDM antigen in the skin and HDM antigen-specific IgE antibody. J Dermatol Sci. 1992;3:73–7.CrossRefPubMedGoogle Scholar
  32. 32.
    Tanaka Y, Tanaka M, Anan S, Yoshida H. Immunohistochemical studies on dust mite antigen in positive reaction site of patch test. Acta Derm Venereol (Stockh). 1989;144:93–6.Google Scholar
  33. 33.
    Tanei R, Hasegawa Y. Double-positive immunoglobulin E+ and Dermatophagoides farinae antigen+ dendritic cells are observed in skin Lesions of older adults with atopic dermatitis: an immunohistological study. Dermatol Clin Res. 2017;3(1):134–50.Google Scholar
  34. 34.
    Novak N, Allam JP, Bieber T. Allergic hyperreactivity to microbial components: a trigger factor of “intrinsic” atopic dermatitis? J Allergy Clin Immunol. 2003;112:215–6.CrossRefPubMedGoogle Scholar
  35. 35.
    Kerschenlohr K, Decard S, Darsow U, Ollert M, Wollenberg A. Clinical and immunologic reactivity to aeroallergens in “intrinsic” atopic dermatitis patients. J Allergy Clin Immunol. 2003:111:195–7.Google Scholar
  36. 36.
    Suárez-Farińas M, Dhingra N, Gittler J, Shemer A, Cardinale I, de Guzman SC, et al. Intrinsic atopic dermatitis shows similar Th2 and higher Th17 immune activation compared with extrinsic atopic dermatitis. J Allergy Clin Immunol. 2013;132:361–70.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Thijs JL, van Seggelen W, Bruijnzeel-Koomen C, de Bruin-Weller M, Hijnen D. New developments in biomarkers for atopic dermatitis. J Clin Med. 2015;4:479–87.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Asai T, Horiuchi Y. Senile erythroderma with serum hyper IgE. Int J Dermatol. 1989;28:255–8.CrossRefPubMedGoogle Scholar
  39. 39.
    Nakano-Tahara M, Terao M, Nishioka M, Kitaba S, Murota H, Katayama I. T helper 2 polarization in senile erythroderma with elevated levels of TARC and IgE. Dermatology. 2015;230:62–9.CrossRefPubMedGoogle Scholar
  40. 40.
    Camacho FM, García-Hernandez MJ, Muñoz-Pérez MA, Mazuecos J, Sotillo I. Ofuji papuloerythroderma in elderly woman with atopic erythroderma. J Eur Acad Dermatol Venereol. 2001;15:264–6.CrossRefPubMedGoogle Scholar
  41. 41.
    Miyagaki T, Sugaya M. Erythrodermic cutaneous T-cell lymphoma: how to differentiate this rare disease from atopic dermatitis. J Dermatol Sci. 2011;64:1–6.CrossRefPubMedGoogle Scholar
  42. 42.
    Furue M, Chiba T, Takeuchi S. Current status of atopic dermatitis in Japan. Asia Pac Allergy. 2011;1:64–72.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Muto T, Hsieh SD, Sakurai Y, Yoshinaga H, Suto H, Okumura K, et al. Epidemiology and health services research prevalence of atopic dermatitis in Japanese adults. Br J Dermatol. 2003;148:117–21.CrossRefPubMedGoogle Scholar
  44. 44.
    Pietschmann P, Gollob E, Brosch S, Hahn P, Kudlacek S, Willheim M, et al. The effect of age and gender on cytokine production by human peripheral blood mononuclear cells and markers of bone metabolism. Exp Gerontol. 2003;38:1119–27.CrossRefPubMedGoogle Scholar
  45. 45.
    Spergel JM, Poller AS. Atopic dermatitis and the atopic march. J Allergy Clin Immunol. 2003;112:S118–27.CrossRefPubMedGoogle Scholar
  46. 46.
    Brenninkmeijer EEA, Spuls PI, Legierse CM, Lindeboom R, Smitt JHS, Bos JD. Clinical differences between atopic and atopiform dermatitis. J Am Acad Dermatol. 2008;58:407–14.CrossRefPubMedGoogle Scholar
  47. 47.
    Irvine AD, McLean WH. Filaggrin mutation associated with skin and allergic diseases. N Engl J Med. 2011;365:1315–27.CrossRefPubMedGoogle Scholar
  48. 48.
    Nomura T, Akiyama M, Sandilands A, Nemoto-Hasebe I, Sakai K, Nagasaki A, et al. Specific filaggrin mutations cause ichthyosis vulgaris and are significantly associated with atopic dermatitis in Japan. J Invest Dermatol. 2008;128:1436–41.CrossRefPubMedGoogle Scholar
  49. 49.
    Enomoto H, Hirata K, Otuka K, Kawai T, Takahashi T, Hirota T, et al. Filaggrin null mutations are associated with atopic dermatitis and elevated levels of IgE in Japanese population: a family and case-control study. J Hum Genet. 2008;53:615–21.CrossRefPubMedGoogle Scholar
  50. 50.
    Tanei R, Noguchi E. Elderly atopic dermatitis in a father and daughter associated with MHC class II allele HLA-DRB1*1501. Dermatol Clin Res. 2016;2(3):95–8. ISSN:2380-5609.Google Scholar
  51. 51.
    Rice NE, Patel BD, Lang IA, Kumari M, Frayling TM, Murray A, et al. Filaggrin gene mutations are associated with asthma and eczema in later life. J Allergy Clin Immunol. 2008;122:834–6.CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Katayama I, Kohno Y, Akiyama K, Ikezawa Z, Kondo N, Tamaki K, et al. Japanese guideline for atopic dermatitis. Allergol Int. 2011;60:205–20.CrossRefPubMedGoogle Scholar
  53. 53.
    Tanei R, Oda A, Hasegawa Y. Narrow-band ultraviolet B is a useful adjunctive treatment for atopic dermatitis in older adults: case reports. Dermatol Clin Res. 2016;2(3):112–7.Google Scholar
  54. 54.
    Nakamura S, Takeda K, Hashimoto Y, Mizumoto T, Ishida-Yamamoto A, Iizuka H. Primary cutaneous CD30+ lymphoproliferative disorder in an atopic dermatitis patient on cyclosporine therapy. Indian J Dermatol Venereol Leprol. 2011;77:253.CrossRefPubMedGoogle Scholar
  55. 55.
    Furue M, Kadono T. New therapies for controlling atopic itch. J Dermatol. 2015;42:847–50.CrossRefPubMedGoogle Scholar
  56. 56.
    Novak N, Bieber T, Hoffmann M, Fölster-Holst R, Homey B, Werfel T, et al. Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis. J Allergy Clin Immunol. 2012;130:925–31.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. outside the USA 2018

Authors and Affiliations

  1. 1.Department of DermatologyTokyo Metropolitan Geriatric Hospital and Institute of GerontologyTokyoJapan

Personalised recommendations